As the global economy recovers in 2021 and the supply of the industrial chain improves, the RNA-Based Therapeutics And Vaccines market will undergo major changes. According to the latest research, the market size of the RNA-Based Therapeutics And Vaccines industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global RNA-Based Therapeutics And Vaccines industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global RNA-Based Therapeutics And Vaccines market during the next few years. The global RNA-Based Therapeutics And Vaccines market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The RNA-Based Therapeutics And Vaccines market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Highlights-Players
Major Players in RNA-Based Therapeutics And Vaccines market are:
Dicerna Pharmaceuticals, Inc.
Moderna Therapeutics, Inc.
Marina Biotech, Inc.
Arrowhead Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
CureVac AG
BioNTech AG
Regulus Therapeutics, Inc.
Santaris Pharma A/S (A Roche Company)
Arbutus Biopharma Corp.
miRagen Therapeutics
Highlights-Types
Most important types of RNA-Based Therapeutics And Vaccines products covered in this report are:
RNA-based Therapeutics
RNA-Based Vaccines
Application listHighlights-Application
Most widely Application of RNA-Based Therapeutics And Vaccines market covered in this report are:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others